Literature DB >> 33337346

The gut microbiome, endocannabinoids and metabolic disorders.

Fabio Arturo Iannotti1, Vincenzo Di Marzo2,3.   

Abstract

Two complex systems are emerging as being deeply involved in the control of energy metabolism. The intestinal microbiota, with its warehouse of genes, proteins and small molecules, that is, the gut microbiome; and the endocannabinoid system, with its recent extension to a more complex signalling apparatus including more than 100 lipid mediators and 50 proteins, that is, the endocannabinoidome. Both systems can become perturbed following bad dietary habits and during obesity, thus contributing to exacerbating this latter condition and its consequences in both peripheral organs and the brain. Here, we discuss some of the multifaceted aspects of the regulation and dysregulation of the gut microbiome and endocannabinoidome in energy metabolism and metabolic disorders, with special emphasis on the emerging functional interactions between the two systems. The potential exploitation of this new knowledge for the development of new pharmacological and nutritional approaches against obesity and its consequences is also briefly touched upon.

Entities:  

Keywords:  endocannabinoidome; endocannabinoids; lipid signals; metabolism; microbiota; obesity

Mesh:

Substances:

Year:  2021        PMID: 33337346     DOI: 10.1530/JOE-20-0444

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  26 in total

Review 1.  Inflammaging and Cannabinoids.

Authors:  Babak Baban; Hesam Khodadadi; Évila Lopes Salles; Vincenzo Costigliola; John C Morgan; David C Hess; Kumar Vaibhav; Krishnan M Dhandapani; Jack C Yu
Journal:  Ageing Res Rev       Date:  2021-10-15       Impact factor: 10.895

Review 2.  Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome.

Authors:  Stuart M Brierley; Beverley Greenwood-Van Meerveld; Giovanni Sarnelli; Keith A Sharkey; Martin Storr; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-09-27       Impact factor: 73.082

Review 3.  Cross-Talk Between Gut Microbiota and Adipose Tissues in Obesity and Related Metabolic Diseases.

Authors:  Dan Wu; Huiying Wang; Lijun Xie; Fang Hu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-05       Impact factor: 6.055

Review 4.  Metabolomics: The Key to Unraveling the Role of the Microbiome in Visceral Pain Neurotransmission.

Authors:  Adam Shute; Dominique G Bihan; Ian A Lewis; Yasmin Nasser
Journal:  Front Neurosci       Date:  2022-06-23       Impact factor: 5.152

Review 5.  Effects of Non-Polar Dietary and Endogenous Lipids on Gut Microbiota Alterations: The Role of Lipidomics.

Authors:  Konstantinos Tsiantas; Spyridon J Konteles; Eftichia Kritsi; Vassilia J Sinanoglou; Thalia Tsiaka; Panagiotis Zoumpoulakis
Journal:  Int J Mol Sci       Date:  2022-04-07       Impact factor: 6.208

Review 6.  The Endocannabinoid System and PPARs: Focus on Their Signalling Crosstalk, Action and Transcriptional Regulation.

Authors:  Fabio Arturo Iannotti; Rosa Maria Vitale
Journal:  Cells       Date:  2021-03-07       Impact factor: 6.600

7.  The Endocannabinoid System in the Mediterranean Mussel Mytilus galloprovincialis: Possible Mediators of the Immune Activity?

Authors:  Francesco Mosca; Osvaldo Zarivi; Natalia Battista; Mauro Maccarrone; Pietro Giorgio Tiscar
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

Review 8.  Cannabidiol and Neurodevelopmental Disorders in Children.

Authors:  Keith A Kwan Cheung; Murray D Mitchell; Helen S Heussler
Journal:  Front Psychiatry       Date:  2021-05-21       Impact factor: 4.157

Review 9.  Mediterranean Diet and Neurodegenerative Diseases: The Neglected Role of Nutrition in the Modulation of the Endocannabinoid System.

Authors:  Federica Armeli; Alessio Bonucci; Elisa Maggi; Alessandro Pinto; Rita Businaro
Journal:  Biomolecules       Date:  2021-05-24

Review 10.  An Autonomous Cannabinoid System in Islets of Langerhans.

Authors:  Kanikkai Raja Aseer; Josephine M Egan
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-05       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.